Pharmaceutical Companies

Health written question – answered on 7th April 2005.

Alert me about debates like this

Photo of John Austin John Austin Labour, Erith and Thamesmead

To ask the Secretary of State for Health what recent representations he has received in relation to conduct of research involving pharmaceutical companies; and if he will make a statement.

Photo of Miss Melanie Johnson Miss Melanie Johnson Parliamentary Under-Secretary, Department of Health

In the context of the United Kingdom Clinical Research Collaboration, pharmaceutical industry representatives and others have drawn attention to inconsistent local administrative requirements of national health service organisations that can delay clinical research. The UK Clinical Research Collaboration includes a work stream on regulatory and governance issues through which the Department is working with its partners to promote processes which operate more efficiently while continuing to providing effective protection for patients.

Representatives of the pharmaceutical industry also recently submitted evidence to an ad hoc group reviewing the operation of the NHS Research Ethics Committee system.

Under the Freedom of Information Act, the Department has received a request for information about clinical trials conducted in the NHS for pharmaceutical companies.

Does this answer the above question?

Yes1 person thinks so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.